General MedicationsINTRAVENOUSStandard

SILDENAFIL CITRATE

Standard Dose

EQ 10MG BASE/12.5ML (EQ 0.8MG BASE/ML)

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview SILDENAFIL CITRATE is listed in Drugs@FDA under application 203988 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient SILDENAFIL CITRATE Form and strength SOLUTION;INTRAVENOUS - EQ 10MG BASE/12.5ML (EQ 0.8MG BASE/ML) Sponsor EUGIA PHARMA Submission history Latest submission status date: 2020-10-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview SILDENAFIL CITRATE is listed in Drugs@FDA under application 203988 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SILDENAFIL CITRATE Form and strength SOLUTION;INTRAVENOUS - EQ 10MG BASE/12.5ML (EQ 0.8MG BASE/ML) Sponsor EUGIA PHARMA Submission history Latest submission status date: 2020-10-22 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.